Association between genetic variation in the myo-inositol monophosphatase 2 (IMPA2) gene and age at onset of bipolar disorder

作者：Tomioka Yoko; Jimenez Esther; Salagre Estela; Arias Barbara; Mitjans Marina; Ruiz Victoria; Saiz Pilar; Paz Garcia Portilla Maria; de la Fuente Lorena; Patricia Gomes da Costa Susana; Bobes Julio; Vieta Eduard^*; Benabarre Antoni; Grande Iria^*

来源：Journal of Affective Disorders, 2018, 232: 229-236.

DOI：10.1016/j.jad.2018.02.002

• Early-onset
• IMPA2
• Genetics
• Bipolar disorder

Introduction: The age at onset of bipolar disorder (BD) has significant implications for severity, duration of affective episodes, response to treatment, and psychiatric comorbidities. It has been suggested that early-onset BD (EO- BD) could represent a clinically distinct subtype with probable genetic risk factors different from those of late-onset BD (LO-BD). To date, several genes have been associated with BD risk but few studies have investigated the genetic differences between EO-BD and LO-BD. The aim of this study was to evaluate if variants of the gene coding for myo-inositol monophosphatase (IMPA2) are linked to age at onset of BD.
Method: 235 bipolar patients were recruited and assessed. The final sample consisting of 192 euthymic individuals, was compared according to the age at onset. Polymorphisms were genotyped in the IMPA2 gene (rs669838, rs1020294, rs1250171, and rs630110). Early-onset was defined by the appearance of a first affective episode before the age of 18.
Results: The analyses showed that in the genotype distribution rs1020294 (p =.01) and rs1250171 (p =.01) were associated with the age at onset. The significant effect remained only in the rs1020294 SNP in which G carriers were more likely to debut later compared to patients presenting the AA genotype (p =. 002; OR = 9.57, CI95%[ 2.37-38.64]). The results also showed that EO- BD tended to experience more alcohol misuse (p =.003; OR =.197, CI95%[.07-.58]) compared to LO-BD.
Conclusions: Our results provide evidence for genetic differences between EO- BD and LO-BD at the IMPA2 gene as well as clinical differences between subgroups with therapeutic implications.

• 出版日期2018-5